1 |
Bird RP (1995). Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93:55-71
DOI
ScienceOn
|
2 |
Cho JW, Park K, Kweon GR., Jang BC, Baek WK, Suh MH, Kim CW, Lee KS & Suh SI (2005). Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Exp Mol Med 37:186-192
DOI
ScienceOn
|
3 |
Daly KT, Tracy AC, Malik M, Wang T, Francke-Carroll S & Magnuson BA (2007). Enhanced estrogenic responses and sensitivity to azoxymethane following dietary soy isoflavone supplementation in older female rats. Food Chem Toxicol 45:628-637
DOI
ScienceOn
|
4 |
Guo JY, Li X, Browning J, Rottinghaus GE, Lubahn DB, Constantinou A, Bennink M, & MacDonald R (2004). Dietary soy isoflavones and estrone protect ovariectomized ERoKO and wild-type mice from carcinogen-induced colon cancer. J Nutr 134:179-182
|
5 |
Jacoby RF, Seibert K, Cole CE, Kelloff G & Lubet RA (2000). The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 60:5040-5044
|
6 |
Ji GE, Kim IH, & Lee SK (1994). Investigation of selective medium for isolation and enumeration of Bacteriodes sp. from the feces of the Korean people. Korean Journal of Food Science and Technology 26:295-299
|
7 |
Khalil DA, Lucas EA., Smith BJ, Soung DY, Devareddy L, Juma S, Akhter MP, Recker AR & Arjmandi BH (2005). Soy isoflavones may protect against archidectomy-induced bone loss in aged male rats. Calcif Tissue Int 76: 50-62
DOI
|
8 |
Lim CC, Ferguson LR, & Tannock GW (2005). Dietary fibers as "prebiotics" : implications for colorectal cancer. Mol Nutr Food Res 49:609-619
DOI
ScienceOn
|
9 |
Ohta A, Uehara M, Sakai K, Takasaki M, Adlercreutz H, Morohashi T & Ishimi Y (2002). A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice. J Nutr 132:2048-2054
|
10 |
Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF & Taketo MM (1996). Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 87:803-809
DOI
ScienceOn
|
11 |
Picherit C, Coxam V, Bennetau-Pelissero C, Kati-coulibaly S, Davicco MJ, Lebecque P & Barlet JP (2000). Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J Nutr 130:1675-1681
|
12 |
Sung HY, Lim YJ & Choi YS (2006). Soy isoflavones do not alter the effects of fructooligosaccharide on the intestinal ecosystem of colon-cancer model rats. Food Sci Biotechnol 15:931-936
과학기술학회마을
|
13 |
Uehara M, Ohta A, Sakai K, Suzuki K, Watanabe S & Adlercreutz H (2001). Dietary fructooligosaccharides modify intestinal bioavailability of a single dose of genistein and daidzein and affect their urinal)' excretion and kinetics in blood of rats, J Nutr 131 :787-795
|
14 |
Messina M & Bennink M (1998). Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data. Baillieres Clin Endocrinol Metab 12:707-728
DOI
ScienceOn
|
15 |
Birt DF, Hendrich S & Wang W (2001). Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90:157-177
DOI
ScienceOn
|
16 |
Sung HY & Choi YS (2008). Fructooligosaccharide and soy isoflavone suppress colonic aberrant crypt foci and cyclooxygenase-2 expression in dimethylhydrazine-treated rats, J Med Food 11:78-85
DOI
|
17 |
WHO (2003). Technical Report Series 916, Diet, Nutrition and the Prevention of Chronic Diseases. pp.95-104, World Health Organization, Geneva, Switzerland
|
18 |
Mathey J, Puel S, Kati-Coulibaly S, Bennetau-Pelissero C, Davicco MJ, Lebecque P, Horcajada MN & Coxam V (2004). Fructooligosaccharides maximize bone-sparing effects of soy isoflavoneenriched diet in the ovariectomized rat. Calcif Tissue Int 75 :169-179
DOI
|
19 |
Onoue M, Kado S, Sakaitani Y, Uchida K & Morotomi M (1997). Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats. Cancer Lett 113:179-186
DOI
ScienceOn
|
20 |
Cummings JH & Bingham SA (1998). Diet and the prevention of cancer. BMJ 317:1636-1640
DOI
|
21 |
Bird RP & Good CK (2000). The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 112-113:395-402
DOI
ScienceOn
|
22 |
American Institute of Nutrition (1993). Report of the ad hoc committee on standards for nutrition studies. J Nutr 123:1939-1951
DOI
|
23 |
Atkinson C, Berman S, Humbert O & Lampe JW (2004). In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J Nutr 134:596-599
|
24 |
Brouwers E, L'homme R, Al-Maharik N, Lapck O, Hampl R, Wahala K, Mikola H & Adlercreutz H. (2003). Time-resolved fluoroimmunoassay for equol in plasma and urine. J Steroid Biochem Mol Biol 84:577-587
DOI
ScienceOn
|
25 |
Sheehan KM, Sheahan K, O'Donoghue DP, MacSweeney F, Conroy RM, Fitzgerald DJ & Murray FE (1999). The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA 282: 1254-1257
DOI
ScienceOn
|
26 |
McClain RM, Wolzm E, Davidovish A, Pfannkuch F, Edwards JA, & Bausch J (2006). Acute, subchronic and chronic safety studies with genistein in rats. Food Chem Taxicol 44:56-80
DOI
ScienceOn
|
27 |
Pierre F, Perrin P, Champ M, Bomet F, Meflah K & Menanteau J (1991). Short-chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice. Cancer Res 57:225-228
|
28 |
Atkinson C, Frankenfeld CL & Lampe JW (2005). Gut bacterial metabolism of soy isoflavone daidzein: Exploring the relevance to human health. Exp Biol Med 230:155-170
DOI
|
29 |
Setchell KDR, Brown NM & Lydeking-Olsen E (2002). The clinical importance of the metabolite Equol - A clue to the effectiveness of soy and its isoflavones. J Nutr 132:3577-3584
|
30 |
Adlercreutz H (1995). Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103:103-112
DOI
|
31 |
Nielsen ILF & Williamson G (2007). Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer 57:1-10
DOI
ScienceOn
|
32 |
Sorensen IK, Kristiansen E, Mortensen A, Nicolaisen GM, Wijnands JAH, van Kranen HJ, & van Kreijl CF (1998). The effect of soy isoflavones on the development of intestinal neoplasia in mouse. Cancer Lett 130:217-225
DOI
ScienceOn
|
33 |
Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A & Harper P (2006). Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 136:3046-3053
|